Literature DB >> 24335304

Enhanced fusion and virion incorporation for HIV-1 subtype C envelope glycoproteins with compact V1/V2 domains.

Marielle Cavrois1, Jason Neidleman, Mario L Santiago, Cynthia A Derdeyn, Eric Hunter, Warner C Greene.   

Abstract

In infected people, the HIV-1 envelope glycoprotein (Env) constantly evolves to escape the immune response while retaining the essential elements needed to mediate viral entry into target cells. The extensive genetic variation of Env is particularly striking in the V1/V2 hypervariable domains. In this study, we investigated the trade-off, in terms of fusion efficiency, for encoding V1/V2 domains of different lengths. We found that natural variations in V1/V2 length exert a profound impact on HIV-1 entry. Variants encoding compact V1/V2 domains mediated fusion with higher efficiencies than related Envs encoding longer V1/V2 domains. By exchanging the V1/V2 domains between Envs of the same infected person or between two persons linked by a transmission event, we further demonstrated that V1/V2 domains critically influence both Env incorporation into viral particles and fusion to primary CD4 T cells and monocyte-derived dendritic cells. Shortening the V1/V2 domains consistently increased Env incorporation and fusion, whereas lengthening the V1/V2 domains decreased Env incorporation and fusion. Given that in a new host transmitted founder viruses are distinguished by compact Envs with fewer glycosylation sites, our study points to fusion and possibly Env incorporation into virions as limiting steps for transmission of HIV-1 to a new host and suggests that the length and/or the N-glycosylation profile of the V1/V2 domain influences these early steps in the HIV life cycle.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24335304      PMCID: PMC3911571          DOI: 10.1128/JVI.02308-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120.

Authors:  C Rizzuto; J Sodroski
Journal:  AIDS Res Hum Retroviruses       Date:  2000-05-20       Impact factor: 2.205

2.  Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics.

Authors:  Jacqueline D Reeves; Stephen A Gallo; Navid Ahmad; John L Miamidian; Phoebe E Harvey; Matthew Sharron; Stefan Pohlmann; Jeffrey N Sfakianos; Cynthia A Derdeyn; Robert Blumenthal; Eric Hunter; Robert W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-20       Impact factor: 11.205

3.  A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes.

Authors:  Marielle Cavrois; Carlos De Noronha; Warner C Greene
Journal:  Nat Biotechnol       Date:  2002-09-30       Impact factor: 54.908

4.  Human immunodeficiency virus fusion to dendritic cells declines as cells mature.

Authors:  Marielle Cavrois; Jason Neidleman; Jason F Kreisberg; David Fenard; Christian Callebaut; Warner C Greene
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.

Authors:  S A Gallo; A Puri; R Blumenthal
Journal:  Biochemistry       Date:  2001-10-16       Impact factor: 3.162

6.  N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism.

Authors:  R A Ogert; M K Lee; W Ross; A Buckler-White; M A Martin; M W Cho
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 7.  Cellular immunity and Chlamydia genital infection: induction, recruitment, and effector mechanisms.

Authors:  Kathleen A Kelly
Journal:  Int Rev Immunol       Date:  2003 Jan-Feb       Impact factor: 5.311

8.  A replication-competent, neutralization-sensitive variant of simian immunodeficiency virus lacking 100 amino acids of envelope.

Authors:  Welkin E Johnson; Jennifer Morgan; Julie Reitter; Bridget A Puffer; Susan Czajak; Robert W Doms; Ronald C Desrosiers
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

9.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

10.  Temporal relationship between V1V2 variation, macrophage replication, and coreceptor adaptation during HIV-1 disease progression.

Authors:  Silvina Masciotra; Sherry M Owen; Donna Rudolph; Chunfu Yang; Bin Wang; Nitin Saksena; Thomas Spira; Subhash Dhawan; Renu B Lal
Journal:  AIDS       Date:  2002-09-27       Impact factor: 4.177

View more
  12 in total

Review 1.  Molecular determinants of the ratio of inert to infectious virus particles.

Authors:  P J Klasse
Journal:  Prog Mol Biol Transl Sci       Date:  2014-12-01       Impact factor: 3.622

2.  Molecular Features of the V1-V4 Coding Region of Sexually Transmitted Human Immunodeficiency Virus Type 1.

Authors:  Jun Yong Choi; Sergei L Kosakovsky Pond; Christy M Anderson; Douglas D Richman; Davey M Smith
Journal:  J Infect Dis       Date:  2017-05-15       Impact factor: 5.226

3.  Phenotypic Correlates of HIV-1 Macrophage Tropism.

Authors:  Kathryn T Arrildt; Celia C LaBranche; Sarah B Joseph; Elena N Dukhovlinova; William D Graham; Li-Hua Ping; Gretja Schnell; Christa B Sturdevant; Laura P Kincer; Macpherson Mallewa; Robert S Heyderman; Annelies Van Rie; Myron S Cohen; Serena Spudich; Richard W Price; David C Montefiori; Ronald Swanstrom
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

4.  The V1 region of gp120 is preferentially selected during SIV/HIV transmission and is indispensable for envelope function and virus infection.

Authors:  Yanpeng Li; Ulf Dittmer; Yan Wang; Jiping Song; Binlian Sun; Rongge Yang
Journal:  Virol Sin       Date:  2016-04-19       Impact factor: 4.327

5.  Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance.

Authors:  Martin J Deymier; Zachary Ende; Angharad E Fenton-May; Dario A Dilernia; William Kilembe; Susan A Allen; Persephone Borrow; Eric Hunter
Journal:  PLoS Pathog       Date:  2015-09-17       Impact factor: 6.823

6.  In silico Analysis of HIV-1 Env-gp120 Reveals Structural Bases for Viral Adaptation in Growth-Restrictive Cells.

Authors:  Masaru Yokoyama; Masako Nomaguchi; Naoya Doi; Tadahito Kanda; Akio Adachi; Hironori Sato
Journal:  Front Microbiol       Date:  2016-02-09       Impact factor: 5.640

7.  Phenotypic and Functional Characterization of Monoclonal Antibodies with Specificity for Rhesus Macaque CD200, CD200R and Mincle.

Authors:  Siddappa N Byrareddy; Dawn Little; Ann E Mayne; Francois Villinger; Aftab A Ansari
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

8.  Breast milk and in utero transmission of HIV-1 select for envelope variants with unique molecular signatures.

Authors:  Kyle J Nakamura; Laura Heath; Edwin R Sobrera; Thomas A Wilkinson; Katherine Semrau; Chipepo Kankasa; Nicole H Tobin; Nicholas E Webb; Benhur Lee; Donald M Thea; Louise Kuhn; James I Mullins; Grace M Aldrovandi
Journal:  Retrovirology       Date:  2017-01-26       Impact factor: 4.602

9.  The HIV-1 transmission bottleneck.

Authors:  Samuel Mundia Kariuki; Philippe Selhorst; Kevin K Ariën; Jeffrey R Dorfman
Journal:  Retrovirology       Date:  2017-03-23       Impact factor: 4.602

10.  HIV-1 Fusion Assay.

Authors:  Marielle Cavrois; Jason Neidleman; Warner C Greene
Journal:  Bio Protoc       Date:  2014-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.